Lymphedema reduction by noninvasive complex lymphedema therapy.
M. Boris, Stanley Weindorf, Bonnie B. Lasinski, Geeta devi Boris
Abstract
M. Boris, Stanley Weindorf, Bonnie B. Lasinski, Geeta devi Boris
Abstract
Noninvasive complex lymphedema therapy (CLT), a technique of manual lymph drainage, compressive bandaging, and specific physical therapy exercises, has been utilized successfully to treat lymphedema in Europe and Australia. This paper reports the results of such therapy in 38 patients (16 females with arm lymphedema secondary to breast surgery, 18 patients with unilateral lower extremity lymphedema, and 4 individuals with bilateral leg disease) for 1 month. Reduction of edema averaged 73% among the patients with arm disease, and 88% among those with leg lymphedema; both reductions are statistically significant. Thirty patients have been followed for up to 1 year. During this period, their average reduction in lymphedema of 80% improved to 86%. We conclude that CLT significantly and safely reduces lymphedema. Reductions not only are maintained after the initial therapy but may increase in magnitude.
OpenAlex reports 139 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Noninvasive complex lymphedema therapy (CLT), a technique of manual lymph drainage, compressive bandaging, and specific physical therapy exercises, has been utilized successfully to treat lymphedema in Europe and Australia. This paper reports the results of such therapy in 38 patients (16 females with arm lymphedema secondary to breast surgery, 18 patients with unilateral lower extremity lymphedema, and 4 individuals with bilateral leg disease) for 1 month. Reduction of edema averaged 73% among the patients with arm disease, and 88% among those with leg lymphedema; both reductions are statistically significant. Thirty patients have been followed for up to 1 year. During this period, their average reduction in lymphedema of 80% improved to 86%. We conclude that CLT significantly and safely reduces lymphedema. Reductions not only are maintained after the initial therapy but may increase in magnitude.
Key concepts: Lymphedema, Medicine, Secondary lymphedema, Edema, Surgery, Breast cancer, Internal medicine, Cancer